Mylan Petitions For Review In Benicar Patent Dispute With U.S. Supreme Court

(October 1, 2015, 2:47 PM EDT) -- WASHINGTON, D.C. — In a drug patent infringement lawsuit over Apotex Inc.’s efforts to end Mylan Pharmaceuticals Inc.’s generic exclusivity for “Benicar” hypertension drug, Mylan in a Sept. 8 petition for...
To view the full article, register now.